指南与共识术前评估与围术期医学疼痛医学

ASRA疼痛医学共识指南:围术期大麻及大麻素使用患者的管理

ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids.
指南 / 共识 · Reg Anesth Pain Med · 2023-01-03

指南涵盖围术期筛查、择期手术推迟、阿片类合用、产妇影响、术中麻醉与镇痛调整、术后监测、大麻使用障碍及术后关注点,指出使用大麻素的手术患者围术期不良结局风险可能增加。

要点

  • 围术期应筛查大麻及大麻素使用情况。
  • 使用大麻素的患者围术期不良结局风险可能增加。
  • 共识涵盖择期手术推迟、术中麻醉调整及术后监测等九大问题。

核心结论

  • 成功制定了针对围术期大麻及大麻素管理的具体临床推荐。
  • 使用大麻素的手术患者围术期不良结局风险可能增加。

研究设计与样本

  • 围术期大麻及大麻素指南委员会负责就九个关键问题起草答复,共识推荐需≥75%同意。

主要发现

  • 九个问题经第三轮投票达成100%共识。
  • 议题包括围术期筛查、择期手术推迟、围术期阿片类与大麻合用、对产妇的影响、术中麻醉与镇痛调整、术后监测、大麻使用障碍及术后关注点。

关键数值与推荐

  • 共识推荐要求≥75%同意。
  • 九个关键问题在第三轮投票中达成100%共识。

临床怎么用

  • 围术期应筛查大麻及大麻素使用。
  • 对使用大麻素的患者应考虑围术期不良结局风险可能增加。
  • 根据共识推荐调整择期手术时机、术中麻醉与镇痛方案及术后监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The past two decades have seen an increase in cannabis use due to both regulatory changes and an interest in potential therapeutic effects of the substance, yet many aspects of the substance and their health implications remain controversial or unclear. METHODS: In November 2020, the American Society of Regional Anesthesia and Pain Medicine charged the Cannabis Working Group to develop guidelines for the perioperative use of cannabis. The Perioperative Use of Cannabis and Cannabinoids Guidelines Committee was charged with drafting responses to the nine key questions using a modified Delphi method with the overall goal of producing a document focused on the safe management of surgical patients using cannabinoids. A consensus recommendation required ≥75% agreement. RESULTS: Nine questions were selected, with 100% consensus achieved on third-round voting. Topics addressed included perioperative screening, postponement of elective surgery, concomitant use of opioid and cannabis perioperatively, implications for parturients, adjustment in anesthetic and analgesics intraoperatively, postoperative monitoring, cannabis use disorder, and postoperative concerns. Surgical patients using cannabinoids are at potential increased risk for negative perioperative outcomes. CONCLUSIONS: Specific clinical recommendations for perioperative management of cannabis and cannabinoids were successfully created.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023. PMID: 36596580. doi:10.1136/rapm-2022-104013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。